insights_auto
Waarom is COR gestegen 2,99%?
Meer informatiechevron_right
COR:NYSE
AmerisourceBergen
US$ 359,03
arrow_upward
+2,99%(+10,42) 1D
13 nov, 16:00:05 GMT-5 · USD
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor COR genereren…
Openen
US$ 351,12
Hoog
US$ 359,39
Laag
US$ 350,11
Beursw.
15,87 mld.
Gem. vol.
1,31 mln.
Volume
13,00
52 wk hoog
US$ 377,54
52 wk laag
US$ 244,82
Bèta
0,58
Uitstaande aandelen
190,83 mln.
Aantal medewerkers
49K
Openen
US$ 351,12
Hoog
US$ 359,39
Laag
US$ 350,11
Beursw.
15,87 mld.
Gem. vol.
1,31 mln.
Volume
13,00
52 wk hoog
US$ 377,54
52 wk laag
US$ 244,82
Bèta
0,58
Uitstaande aandelen
190,83 mln.
Aantal medewerkers
49K
Nieuwsartikelen
Van webbronnen en nieuwspartners
Investing.com
·
2 dagen geleden
US FTC sues to block Cencora’s $3.5 billion sale of veterinary unit to Covetrus By Reuters
Profiel
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area. Wikipedia
Over AmerisourceBergen
CEORobert Mauch
Medewerkers49K
Opgericht1871
Hoofdkantoor-
SectorHealth Care
Industrie-
Websitecencora.com